First Derm

FEBRUARY 21, 2024

Social media significantly influences the popularity of retinol among young people, leading to increased experimentation without considering safety. There’s a crucial difference between cosmetic retinol use and medical treatment with retinoids ; the latter is for specific skin conditions under professional supervision.

Retinol 80

Retinol Social Media Skincare Routine Skincare 80

The Dermatology Digest

JANUARY 21, 2024

Delgocitinib cream continues to perform well in chronic hand eczema (CHE), with limited systemic exposure, according to two studies presented at the 2024 Maui Dermatology conference. What’s more, delgocitinib cream 20 mg/g was well-tolerated over 16 weeks, and no safety concerns were identified. Study author Melinda J.

Safety 36

Safety Eczema Social Media Dermatology 36

The Dermatology Digest

FEBRUARY 14, 2024

“We are thankful to the patients and medical experts whose insights informed our clinical trials, which assessed nemolizumab’s ability to reduce the symptoms of itch and skin lesions. Nemolizumab was generally well tolerated and its safety profile was similar to placebo across the OLYMPIA and ARCADIA clinical trial programs.

Dermatitis 78

Dermatitis Clinic Safety Dermatology 78

First Derm

DECEMBER 26, 2023

Recent studies indicate that dry, itchy scalp is a significant global issue, with about 40% of the world’s population seeking medical help for symptoms related to scalp dryness. [1] Skin Conditions (Eczema, Psoriasis, Contact Dermatitis) as Causes of Dry, Itchy Scalp Various skin conditions can lead to a dry, itchy scalp: a.

Management 49

Management Dermatitis Eczema Consultations 49

The Dermatology Digest

JANUARY 30, 2024

Five investigators have received funding through the 2023 PeDRA Research Grants, Career Bridge Research Grant, Pediatric Alopecia Areata Challenge Grant, and Childhood Eczema Challenge Grant programs. The post And the Winners Are…PeDRA Announces 2023 Grant Recipients appeared first on The Dermatology Digest.

Partnerships 36

Partnerships Eczema Hospital Dermatology 36

Eminence Organics

JULY 3, 2024

In comparison, facial razors are tools that feature a safety guard and sit on the skin at a 35-degree angle and were designed to be used at home. She explains the difference between professional dermaplaning and using a razor at home: “In the treatment, they use a surgical blade at a 45-degree angle for the main purpose of exfoliation.

Dermaplaning 98

Dermaplaning Hair Removal Facials Tools 98

The Dermatology Digest

DECEMBER 14, 2023

The National Eczema Association (NEA) announced the recipients for its 2023 research grants. The 2023 research grantees include: The Champion Research Grant encourages researchers to continue research on emerging or ongoing challenges in eczema or bring their expertise to the field of eczema.

Eczema 36

Eczema Dermatitis Hospital Networking 36

The Dermatology Digest

MAY 6, 2024

The Phase 2a trial ( NCT05984784 ) evaluates the safety, pharmacokinetics, and efficacy of IMG-007 in adult patients with moderate-to-severe AD who had inadequate response to and/or intolerant of topical therapies. Topical or systemic AD medications were not permitted during the study. and Canada. with IGA=4.

Safety 36

Safety Therapy Dermatitis Eczema 36

The Dermatology Digest

JANUARY 11, 2024

of atopic dermatitis (AD) patients using Vtama (tapinarof) cream, 1% achieved Eczema Area and Severity Index (EASI )75 in an integrated analysis of all the ADORING Program studies, Dermavant reports. Storrs Medical Dermatology Professor and Director of CLEAR Eczema Center, at the Oregon Health & Science University, in a news release.

Dermatitis 36

Dermatitis Safety Eczema Sensitive Skin 36

The Dermatology Digest

MARCH 10, 2024

No new safety signals were observed and there were no serious adverse events reported. Professor of Clinical Dermatology and Vice Chair for Diversity and Inclusion in the Department of Dermatology at Weill Cornell Medicine, a dermatologist at New York-Presbyterian/Weill Cornell Medical Center, in a news release. .

Skin Types 36

Skin Types Fitzpatrick Scale Dermatitis Safety 36

The Dermatology Digest

JANUARY 14, 2024

The overwhelming majority of people with atopic dermatitis (AD) treated with investigational roflumilast cream 0.15% (Zoryve, Arcutis) showed a measurable improvement in Eczema Area and Severity Index (EASI) in 4 weeks, according to new pooled analyses from two Phase 3 studies. Fully 91.5% Importantly, EASI-90 was observed in 22.4%

Dermatitis 36

Dermatitis Safety Dermatology Hospital 36

The Dermatology Digest

OCTOBER 26, 2024

These findings indicate that upadacitinib may address an unmet medical need in patients with moderate-to-severe AD who do not achieve an adequate response while taking dupilumab,” conclude researchers who were led by Christopher Bunick, MD, PhD, an Associate Professor of Dermatology at Yale University in New Haven, CT.

Dermatitis 36

Dermatitis Treatments Pharmaceutical Eczema 36

The Dermatology Digest

DECEMBER 20, 2023

Tim Raducha-Grace Named Chief Platform Officer at Zerigo Health Tim Raducha-Grace is the new Chief Platform Officer at Zerigo Health, a connected phototherapy platform that couples a handheld Narrow-band ultraviolet B (NB-UVB) light device with a smartphone app and team of care providers to allow patients to treat psoriasis and eczema at home.

Dermatology 36

Dermatology Surgery Eczema Office 36

US Dermatologt Partners

MARCH 27, 2024

Thus began research into the potential medicinal uses of red light therapy for a variety of health conditions, which is already widely medically accepted in its use as photodynamic therapy. Improves psoriasis , rosacea , acne , and eczema side effects. Safety and Side Effects This procedure is considered safe.

Therapy 41

Therapy Treatments Dermatology Collagen 41

The Dermatology Digest

SEPTEMBER 25, 2024

307) 67.8 (320) 320) 75.9 (323) 323) 4 to 7.2 severe) 10.5 (152) 152) 47.2 (142) 142) 63.2 (136) 136) Minimal Disease Activity (MDA; EASI 90 + WP-NRS 0/1) 0 to <1 (no-to-mild) 3.1 (97) 108) 1 to <4 (moderate) 2.0 (304) 304) 22.3 (319) 319) 37.5 (320) 320) 4 to 7.2 severe) 0.7 (150) 150) 24.8 (141) 141) 37.8 (135) 283) 25.3 (296) 296) 38.0 (295)

Dermatitis 36

Dermatitis Dermatology Eczema Safety 36

The Eco Well Blog

MAY 8, 2023

Her area of clinical expertise is in complex medical dermatology, skin cancer, and acne. She has published numerous articles in peer-reviewed medical journals on the science of the skin barrier, electron microscopy, and congenital skin diseases. She holds a B.S. SPF 15 SPONSORS GENERAL SPONSORS

Legal 52

Legal Technology Sun Protection Branding 52

The Dermatology Digest

JANUARY 8, 2024

Kimball, MD, MPH, a professor of Dermatology at Harvard Medical School and the President and CEO of Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center in Boston, in a news release. These data will be presented at a future medical congress. Serious adverse events (SAEs) occurred in 5.3%

Medical 36

Medical Clinic Therapy Eczema 36

The Dermatology Digest

DECEMBER 21, 2023

This was first reported by study co-author Stuart Turvey, MBBS, DPHIL, FRCPC in 2017 in patients with an immune dysregulatory and hypereosinophilic syndrome characterized by severe eczema and asthma.

Dermatitis 36

Dermatitis Eczema Safety Dermatology 36

The Dermatology Digest

DECEMBER 18, 2023

The new AD guidelines also: • Highlight the safety of the topical calcineurin inhibitors with typical usage once or twice daily. Urge consideration for once-daily dosing of topical medications. Recommend proactive therapy with topical corticosteroids or topical calcineurin inhibitors for patients with a relapsing course of AD.

Dermatitis 36

Dermatitis Partnerships Therapy Diet 36

US Dermatologt Partners

JANUARY 24, 2024

That starts with a complete medical and health history followed by a discussion of all current and past psoriasis symptoms and the development of a care plan. Thirty years ago, treatments were limited to crude methods such as tar, topical steroids, and medications with significant risks.

Management 36

Management Skin Health Medical Dermatology 36

US Dermatologt Partners

SEPTEMBER 23, 2024

We know that UV radiation and environmental toxins damage the cells in our skin and increase risks for medical conditions such as skin cancer, as well as accelerate the aging process cosmetically. Chronic skin conditions – poorly managed chronic skin conditions like eczema and dermatitis may damage or dilate blood vessels around the eyes.

Treatments 41

Treatments Chemical Peels Skincare Routine Sun Protection 41

Lydia Sarfati

MARCH 13, 2024

A recently published study from the Cleveland Clinic shows that integrative therapies that include massage therapy, can improve the physical, mental and social health for patients with chronic, non-cancer related pain without increased use of opioid medications. MLD has been incorporated into medical esthetics prior and after plastic surgery.

Facial Massage 45

Facial Massage Facials Surgery Tools 45

Aesthetics Advisor

JUNE 18, 2024

Many factors, such as genetics, aging, lifestyle choices, underlying medical conditions, and UV exposure, can contribute to the development of dark circles. Consider medical treatments: Fillers, laser therapy, and surgery may be required for severe or persistent dark circles.

Vitamin C 36

Vitamin C Extractions Hydration Makeup 36

US Dermatologt Partners

JANUARY 7, 2025

Estrogen is key to maintaining skin integrity, said Dr. Susan Massick, a dermatologist at the Ohio State University Wexner Medical Center. Because of these potential safety concerns and the lack of evidence of benefit, Dr. Watchmaker and the other dermatologists recommended not using estrogen as skin care until more research is done.

Collagen 36

Collagen Wrinkles Vitamin C Pharmaceutical 36

The Dermatology Digest

AUGUST 4, 2023

According to Dr. Richard, today she uses many approaches, including biologics (as monotherapy and in combination), as well as phototherapy, to treat patients with psoriasis, eczema, vitiligo, and a “laundry list” of other skin diseases that respond to light. Phototherapy usage trends in the U.S. Many patients prefer non-systemic options.

Eczema 36

Eczema Private Practice Therapy Dermatitis 36

The Dermatology Digest

FEBRUARY 24, 2025

of children treated with roflumilast cream achieved a 75% improvement in the Eczema Area and Severity Index (EASI-75) at Week 4 compared to 20.6% Safety and tolerability results were consistent with previous trials of roflumilast cream 0.15% in patients aged 6 years with AD. Fully 35.3% for vehicle-treated subjects. of patients.

Eczema 67

Eczema Dermatitis Safety Dermatology 67